Compound Detail
CHEMBL5403460
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5403460 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QYAQGBIWBQXKBE-QHCPKHFHSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
378.5
MW (Da)
6.18
ALogP
3
HBA
2
HBD
49.7
PSA (Ų)
0.61
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.54
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Hep 3B2 | IC50 | = | 2910.0 | nM | 5.54 | Cytotoxicity against human Hep3B cells assessed as inhibition of cell proliferat... | 36549116 |
| HepG2 | IC50 | = | 12320.0 | nM | 4.91 | Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferat... | 36549116 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36549116 | 10.1016/j.ejmech.2022.115006 | Hep 3B2 | 1 |
| 36549116 | 10.1016/j.ejmech.2022.115006 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine